NAA10 as a New Prognostic Marker for Cancer Progression.

Sun Myung Kim, Eunyoung Ha, Jinyoung Kim, Chiheum Cho, So-Jin Shin, Ji Hae Seo

Journal: International journal of molecular sciences 2021;21(21):8010

PMID: 33126484

Abstract

N-α-acetyltransferase 10 (NAA10) is an acetyltransferase that acetylates both N-terminal amino acid and internal lysine residues of proteins. NAA10 is a crucial player to regulate cell proliferation, migration, differentiation, apoptosis, and autophagy. Recently, mounting evidence presented the overexpression of NAA10 in various types of cancer, including liver, bone, lung, breast, colon, and prostate cancers, and demonstrated a correlation of overexpressed NAA10 with vascular invasion and metastasis, thereby affecting overall survival rates of cancer patients and recurrence of diseases. This evidence all points NAA10 toward a promising biomarker for cancer prognosis. Here we summarize the current knowledge regarding the biological functions of NAA10 in cancer progression and provide the potential usage of NAA10 as a prognostic marker for cancer progression.

Address: Department of Gynecology and Obstetrics and Institute for Cancer Research, School of Medicine, Keimyung University, Daegu 42601, Korea.; Department of Biochemistry, School of Medicine, Keimyung University, Daegu 42601, Korea.; Department of Internal Medicine, School of Medicine, Keimyung University, Daegu 42601, Korea.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.